| The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States M Schoch-Spana, EK Brunson, R Long, A Ruth, SJ Ravi, M Trotochaud, ... Vaccine 39 (40), 6004-6012, 2021 | 246 | 2021 |
| Rethinking the benefits and costs of childhood vaccination: the example of the Haemophilus influenzae type b vaccine T Bärnighausen, DE Bloom, D Canning, A Friedman, OS Levine, ... Vaccine 29 (13), 2371-2380, 2011 | 111 | 2011 |
| Words matter: Vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination MZ Dudley, L Privor-Dumm, È Dubé, NE MacDonald Vaccine 38 (4), 709-711, 2020 | 84 | 2020 |
| Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria CB Wonodi, L Privor-Dumm, M Aina, AM Pate, R Reis, P Gadhoke, ... Health policy and planning 27 (suppl_2), ii27-ii38, 2012 | 72 | 2012 |
| A global agenda for older adult immunization in the COVID-19 era: a roadmap for action LA Privor-Dumm, GA Poland, J Barratt, DN Durrheim, MD Knoll, ... Vaccine 39 (37), 5240-5250, 2021 | 69 | 2021 |
| Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience RA Hajjeh, L Privor-Dumm, K Edmond, R O’Loughlin, S Shetty, ... Vaccine 28 (43), 7123-7129, 2010 | 61 | 2010 |
| Community-based strategies to engage pastors can help address vaccine hesitancy and health disparities in black communities L Privor-Dumm, T King Journal of health communication 25 (10), 827-830, 2020 | 58 | 2020 |
| Global use of Haemophilus influenzae type b conjugate vaccine LR Ojo, RE O’Loughlin, AL Cohen, JD Loo, KM Edmond, SS Shetty, ... Vaccine 28 (43), 7117-7122, 2010 | 53 | 2010 |
| Interim framework for COVID-19 vaccine allocation and distribution in the United States E Toner, A Barnill, C Krubiner, J Bernstein, L Privor-Dumm, M Watson, ... Baltimore: Johns Hopkins Center for Health Security, 2020 | 51 | 2020 |
| A policy framework for accelerating adoption of new vaccines OS Levine, R Hajjeh, J Wecker, T Cherian, KL O’Brien, MD Knoll, ... Human vaccines 6 (12), 1021-1024, 2010 | 46 | 2010 |
| Supply and delivery of vaccines for global health JL Excler, L Privor-Dumm, JH Kim Current opinion in immunology 71, 13-20, 2021 | 37 | 2021 |
| Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low-and middle-income countries M Sauer, P Vasudevan, A Meghani, K Luthra, C Garcia, MD Knoll, ... Vaccine 39 (11), 1556-1564, 2021 | 36 | 2021 |
| One size does not fit all: the impact of primary vaccine container size on vaccine distribution and delivery LA Haidari, B Wahl, ST Brown, L Privor-Dumm, C Wallman-Stokes, ... Vaccine 33 (28), 3242-3247, 2015 | 36 | 2015 |
| Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India AD Clark, UK Griffiths, SS Abbas, KD Rao, L Privor-Dumm, R Hajjeh, ... The Journal of pediatrics 163 (1), S60-S72, 2013 | 28 | 2013 |
| Pneumococcal conjugate vaccine (PCV) product assessment O Cohen, M Knoll, K O’Brien, M Ramakrishnan, D Constenla, ... Balt MD Johns Hopkins Bloom Sch Public Heal, 2017 | 25 | 2017 |
| Archetype analysis of older adult immunization decision-making and implementation in 34 countries L Privor-Dumm, P Vasudevan, K Kobayashi, J Gupta Vaccine 38 (26), 4170-4182, 2020 | 24 | 2020 |
| The promise of disease detection dogs in pandemic response: lessons learned from COVID-19 CM Otto, TK Sell, TG Veenema, D Hosangadi, RA Vahey, ND Connell, ... Disaster medicine and public health preparedness 17, e20, 2023 | 18 | 2023 |
| Vaccine access, equity and justice: COVID-19 vaccines and vaccination L Privor-Dumm, JL Excler, S Gilbert, SSA Karim, PJ Hotez, D Thompson, ... BMJ Global Health 8 (6), e011881, 2023 | 17 | 2023 |
| Improving access to essential medicines through public-private partnerships K Hayford, L Privor-Dumm, O Levine Baltimore: International Vaccine Access Center, 2011 | 15 | 2011 |
| Factors, enablers and challenges for COVID-19 vaccine development JL Excler, M Saville, L Privor-Dumm, S Gilbert, PJ Hotez, D Thompson, ... BMJ Global Health 8 (6), e011879, 2023 | 13 | 2023 |
